TR-412

N/A

Report date: 2025/07/11 16:10:33

NME

Base Information

Drug NameTR-412

Drug Alias NameTR-412

ClassificationOther

Mechanisms of ActionDual specificity protein kinase CLK2 inhibitorsDual specificity protein kinase CLK3 inhibitorsDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors +[4]

TargetsDual specificity protein kinase CLK2Dual specificity protein kinase CLK3Dual-specificity tyrosine-phosphorylation regulated kinase 1A +[4]

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesTarapeutics Science Inc

China Registration ClassN/A

Develop Information

Active CompaniesTarapeutics Science Inc

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A